APA (7th ed.) Citation

Olsen, I. H., Sørensen, J. B., Federspiel, B., Kjaer, A., Hansen, C. P., Knigge, U., & Langer, S. W. Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas. Wiley.

Chicago Style (17th ed.) Citation

Olsen, Ingrid H., Jens B. Sørensen, Birgitte Federspiel, Andreas Kjaer, Carsten P. Hansen, Ulrich Knigge, and Seppo W. Langer. Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas. Wiley.

MLA (9th ed.) Citation

Olsen, Ingrid H., et al. Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas. Wiley.